179 related articles for article (PubMed ID: 25403849)
1. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
2. Mammography rates for breast cancer screening: a comparison of First Nations women and all other women living in Manitoba, Canada, 1999-2008.
Demers AA; Decker KM; Kliewer EV; Musto G; Shu E; Biswanger N; Fradette K; Elias B; Griffith J; Turner D
Prev Chronic Dis; 2015 May; 12():E82. PubMed ID: 26020546
[TBL] [Abstract][Full Text] [Related]
3. Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study.
Martens PJ; Chochinov HM; Prior HJ; Fransoo R; Burland E;
Schizophr Res; 2009 Aug; 113(1):101-6. PubMed ID: 19419843
[TBL] [Abstract][Full Text] [Related]
4. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
5. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
7. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap.
Dinkelspiel H; Fetterman B; Poitras N; Kinney W; Cox JT; Lorey T; Castle PE
J Low Genit Tract Dis; 2014 Jan; 18(1):57-60. PubMed ID: 24022057
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer Screening and Sexual Risky Behaviors among a Population of Hispanic Origin.
González D; Suárez EL; Ortiz AP
Womens Health Issues; 2015; 25(3):254-61. PubMed ID: 25840931
[TBL] [Abstract][Full Text] [Related]
11. Papanicolaou test utilization and frequency of screening opportunities among women diagnosed with cervical cancer.
Decker K; Demers A; Chateau D; Musto G; Nugent Z; Lotocki R; Harrison M
Open Med; 2009; 3(3):e140-7. PubMed ID: 21603052
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening in first nations people living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Musto G; Shu E; Biswanger N; Elias B; Griffith J; Turner D
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):241-8. PubMed ID: 25336562
[TBL] [Abstract][Full Text] [Related]
13. Utilization patterns of cervical cancer screening in Italy.
Barbadoro P; Ricciardi A; Di Tondo E; Vallorani S; Mazzarini G; Prospero E
Eur J Cancer Prev; 2015 Mar; 24(2):135-40. PubMed ID: 24977627
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of screening in preventing cervical cancer among older women.
Kamineni A; Weinmann S; Shy KK; Glass AG; Weiss NS
Cancer Causes Control; 2013 Sep; 24(9):1653-60. PubMed ID: 23744043
[TBL] [Abstract][Full Text] [Related]
17. Inequities in cervical cancer screening among Colombian women: a multilevel analysis of a nationwide survey.
Bermedo-Carrasco S; Peña-Sánchez JN; Lepnurm R; Szafron M; Waldner C
Cancer Epidemiol; 2015 Apr; 39(2):229-36. PubMed ID: 25707752
[TBL] [Abstract][Full Text] [Related]
18. Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.
Kim M; Kim H; Suh DH; Kim YB
Cancer Res Treat; 2021 Jul; 53(3):813-818. PubMed ID: 33321565
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence, morbidity, and survival in Canadian first nation children: a Manitoba population-based study from the cancer in young people in Canada (CYP-C) registry.
Stammers DM; Israels SJ; Lambert PJ; Cuvelier GD
Pediatr Blood Cancer; 2014 Dec; 61(12):2164-9. PubMed ID: 24616082
[TBL] [Abstract][Full Text] [Related]
20. Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study.
Singh H; Nugent Z; Demers AA; Bernstein CN
Inflamm Bowel Dis; 2011 Aug; 17(8):1741-50. PubMed ID: 21744429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
